n 1992, Brugada and Brugada identified a group of patients without demonstrable structural heart disease who had a unique electrocardiogram (ECG) pattern consisting of a right bundle branch block (RBBB) with ST segment elevation in leads V1-3. 1 This later became known as Brugada syndrome (BS).
Since the first description of the syndrome, the number of cases identified worldwide has increased exponentially. 2 Patients with BS might have a personal or family history of sudden cardiac death or syncope. Arrhythmias such as premature ventricular contraction, monomorphic ventricular tachycardia, [3] [4] [5] polymorphic ventricular tachycardia, and ventricular fibrillation (VF) 1,2,6 and a high incidence of positive ventricular late potentials have been reported in patients with BS. [7] [8] [9] The discovery of associated mutations of the sodium channel gene in some patients confirmed the primary electrical nature of the disease. 10, 11 If BS is a sodium channel disease, it is possible that an electrical abnormality exists not only in the ventricular myocardium but also in the atrial myocardium. There is evidence that some patients with BS exhibit paroxysmal atrial fibrillation (AF) and/or sick sinus syndrome. [12] [13] [14] [15] [16] [17] However, only a few studies have reported on the mechanisms that explain the association of BS with AF. 12, 18 Thus, in this study, we evaluated the electrical abnormalities of the atrial myocardium based on the filtered P-wave duration (FPD) using the P-wave triggered signalaveraged ECG and on atrial vulnerability tested by atrial premature stimulation.
Methods

Study Population
The study subjects comprised 15 consecutive patients with BS and Brugada-type ECG from December 2000 to April 2003; 14 men and 1 woman, ranging in age from 30 to 73 years (mean 53±13 years) who did not suffer from structural heart disease, congestive heart failure and hyperBackground There is evidence that some patients with Brugada syndrome (BS) exhibit atrial tachyarrhythmias including paroxysmal atrial fibrillation. We investigated whether BS associated not only with vulnerability to ventricular fibrillation, but also with vulnerability to atrial fibrillation.
Methods and Results
In 15 patients with BS and Brugada-type electrocardiogram (ECG) (14 men, 1 woman; age 52.8±12.9 years) and 15 age-matched control patients (12 men, 3 women; age 50.9±18.9 years), the P-wave signal-averaged ECG was recorded, and the filtered P-wave duration was derived from the vector magnitude obtained by X, Y, Z leads. In 11 of the 15 patients with BS and Brugada-type ECG, invasive electrophysiologic testing was conducted. Filtered P-wave duration was significantly increased in patients with BS and Brugadatype ECG in comparison with control subjects (143.2±12.9 vs 129.6±10.1 ms, p<0.001). Ventricular late potential (root mean square voltage <20 V in the last 40 ms and <40 V at a low amplitude signal duration >38 ms) was present in 10 of the 12 BS patients in whom a QRS wave signal-averaged electrogram was also recorded. In all 11 patients with Brugada-type ECG who underwent electrophysiologic testing, sustained atrial fibrillation (>5 min) was induced by 1 or 2 atrial extrastimuli. In 10 of these 11 patients, ventricular fibrillation was also induced by 2 or 3 right ventricular extrastimuli. 17 In 1 patient, Wolff-Parkinson-White (WPW) syndrome and atrioventricular nodal re-entrant tachycardia (AVNRT) were first diagnosed, and BS was diagnosed after accessory pathway ablation. BS was accompanied by AVNRT in another patient. These 2 patients had documented episodes of supraventricular tachycardia. Three patients experienced aborted sudden death, 1 patient experienced syncope, 2 patients experienced palpitations, 1 patient experienced chest oppressions, and 7 patients were asymptomatic. In 3 of the 4 patients with syncope, VF was documented. Three patients had a family history of sudden cardiac death.
Conclusions
In the 4 patients in whom the electrophysiologic study was not performed, BS was diagnosed on the basis of apparent coved-type ST-segment elevation in V1-3, saddleback-type ST-segment elevation, or subtle coved-type ST-segment elevation, which became apparent after coved-type ST-segment elevation occurred after the intravenous administration of the class Ic antiarrhythmic drug, pilsicainide (1 mg/kg). No patient had a history of documented AF prior to the diagnosis of Brugada-type ECG.
The mean left ventricular ejection fraction was 65±12%. Fifteen patients with no structural heart disease, hypertension, congestive heart failure and no history of AF or VF in whom an electrophysiological study was performed to evaluate palpitations or syncope, served as control subjects. Twelve of these patients were men and 3 were women; their mean age was 51±19 years. The mean left ventricular ejection fraction was 68±7%.
Electrophysiologic Study
All patients gave informed consent to participate in the present study, which was approved by the Clinical Research and Ethics Committee of Nihon University Hospital. An electrophysiologic study was performed in 11 of the 15 patients with BS and 15 control patients who were drug free. Programmed ventricular stimulation was performed with 2 or 3 extrastimuli from the right ventricular apex or outflow tract at basic cycle lengths of 600 or 500 and 400 ms ( Table 2 ). S2 was shortened to the effective refractory period (ERP), but the shortest coupling intervals of S3 and S4 were limited to 190 ms. In these 11 patients, programmed atrial stimulation with up to 2 extrastimuli from the high right atrium (RA) was also performed at basic cycle lengths of 750 or 600 and 400 ms ( Table 2 ). S2 and S3 were shortened to the ERP (Table 2) .
Signal-Averaged ECG
The ventricular signal-averaged ECG (using ART 1200 EPX signal-averaged ECG apparatus; ART Co, Austin, TX, USA) was recorded in 12 of the15 patients with BS. Positive late potential characterizing BS is defined in our institution as the root mean square voltage of the last 40 ms <20 V. 8 The P-wave signal-averaged ECG was recorded in all 15 controls by using a P-wave triggered and bidirectionally filtered mode (MAC VU ECG unit; Marquette Co, Milwaukee, WI, USA). The FPD was calculated from the vector magnitude of the X, Y, Z leads. P-wave signal-averaged ECG was accepted when the noise level was less than 0.5 V. In all the control patients, the P-wave signal-averaged ECG was recorded while they were drug free. The FPD was calculated automatically by using the MAC VU ECG unit, and the end of the filtered P-wave was corrected visually by 2 independent investigators, based on the end of the filtered P-wave amplitude that entered the baseline noise envelope. We used the FPD as the index of atrial conduction abnormalities because other indices such as the last 
Statistical Analysis
Results are expressed as mean ± SD. Mann-Whitney's U-test was used for data analysis of the FPD between BS patients and control subjects. A p-value of <0.05 was considered to be statistically significant.
Results
Electrophysiologic Study
In the 11 patients with BS, the mean atrio-His (AH) interval was 92.3±18.6 ms, and the mean His-ventricular (HV) interval was 60.2±12.3 ms. The mean RA ERP, at a cycle length of 600 ms, was 196.6±28.3 (160-240) ms (Table 2) . AF lasting >5 min was induced in 11 of the 11 patients (100%) who underwent an electrophysiological study ( Table 2 ; Figs 1-5) . VF was induced in 10 of these 11 patients (91%) ( Table 2 ; Figs 1-5) . Atrioventricular re-entrant tachycardia and AVNRT were induced in case 1 and AVNRT and common-type atrial flutter were induced in case 11. No sustained AF and VF could be induced in 15 control patients, and repetitive atrial response lasting less than 3 s were induced in 6 of the 15 control patients. Of these 15 control patients, 4 patients had concealed WPW syndrome, 3 patients had AVNRT, 3 patients had atrial tachycardia, 3 patients had right ventricular outflow tract ventricular tachycardia and 2 patients were finally diagnosed as having vasovagal syncope. In the 15 control patients, the mean AH interval was 76.3±24.6 ms (NS vs BS), and the mean HV interval was 48.2±9.3 ms (NS vs BS). The mean RA ERP at a cycle length of 600 ms was 206.6± 
(170-245) ms (NS vs BS).
Signal-Averaged ECG
The mean FPD in the BS and control patients was 143.2± 12.9 and 129.6±10.1 ms, respectively (p<0.01). Ventricular late potential was present in 10 of the 12 patients (83%) with BS in whom a signal-averaged ventricular ECG was recorded. No ventricular late potential was present in the 15 control patients.
Discussion
Incidence and Mechanism of AF in Patients With BS
Eckardt et al reported that supraventricular tachyarrhythmia was induced by programmed atrial stimulation in 10 of 35 patients with BS, and 1 of 10 supraventricular tachyarrhythmias was shown to be AF. 15 Itoh et al reported that paroxysmal AF was present in 9 of 30 patients (30%) with BS. 13 Morita et al showed that spontaneous AF was present in 7 of 18 patients (39%) with BS and that AF was induced by programmed atrial stimulation in 8 of 14 patients (57%) with BS. 12 Bordachar et al reported that in 12 of 59 patients (20%) with BS, 10 exhibited paroxysmal AF, 1 exhibited atrial flutter, and 1 exhibited both AF and atrial flutter during a median follow-up period of 32 (11-52) months. 16 In the present study, no patient had a history of AF, and no AF episode was documented during the median follow-up period of 15 (12-27) months. However, unlike other reported incidences of AF, AF was induced in a very high percentage of patients (11 of 11 patients, 100%) by programmed atrial stimulation. The stimulation protocols of Eckardt et al 15 and Morita et al 12 involved 1 extrastimulus. Our protocol for induction of AF included 2 basic cycle lengths and up to 2 extrastimuli. Thus, the higher AF induction rate compared with that in previous reports 11, 13 might be explained by the aggressive protocol used in the present study. One previous report showed that the RA ERP did not differ between Brugada patients and control patients (247.1±27.0 vs 243.3±20.6 ms), 12 whereas in the present study, the RA ERP in Brugada patients (196.6± 28.3 ms) was shorter. Thus, larger studies are needed to compare the ERPs of the atrium of Brugada patients and healthy subjects. In the present study the FPD characterizing BS was longer than that in the control patients. Osaka et al also reported that FPD by P-wave triggered signalaveraged ECG in patients with BS was significantly longer (143.7±10.3 vs 122.3±9.9 ms, p<0.0001) than that of control patients. 18 Morita et al reported that the inter-atrial conduction time of the basic cycle length did not differ between Brugada patients and control patients, but the inter-atrial conduction time at the RA ERP was increased in the Brugada patients compared with the control patients (168.4±59.3 vs 131.8±13.0 ms, p<0.001). 12 The duration of the atrial potential at the RA ERP was also prolonged in the BS patients vs the control patients (80.3±18.0 vs 59.3± 9.2 ms, p<0.001). Thus, increased atrial vulnerability in patients with BS might be caused mainly by longer intraatrial conduction abnormalities and shorter RA ERP. Different from the results of Morita et al, 12 in the present study the FPD was significantly longer in patients with BS compared with control patients. The different data on the interatrial conduction time might be caused by the different methodologies and also because the filtered P wave included activation of both the pulmonary vein antrum and inside the pulmonary veins. 19 
Definition of Positive Late Potential in BS
Previous studies on signal-averaged ECG in patients with BS defined late potential as being positive when 2 criteria (root mean square voltage of the last 40 ms (RMS40) <20 V and duration of low-amplitude signals <40 V in the terminal filtered QRS complex (LAS40) >38 ms) are present. 7, 9 However, it has been demonstrated that RBBB shortens the RMS40 and prolongs LAS40, 20 and Ajiro et al showed the importance of RMS40 in predicting the history of lifethreatening arrhythmic events and the recurrence of VF. 9 Thus, we adopted RMS40 <20 V as the positive late potential in the present study. 
Therapeutic Implications
Previous studies show an increased incidence of atrial arrhythmia in patients with BS. 11, 12, 17 Thus, palpitations in patients with BS are a warning of the possibility of atrial arrhythmia. Conversely, in patients with atrial arrhythmia or with aborted sudden cardiac death or syncope not related to atrial arrhythmia, BS should be considered as a possible additional electrophysiologic abnormality. Furthermore, Bordachar et al reported that in patients with BS who had an implantable cardioverter defibrillator (ICD), 10.5% received appropriate ICD shocks, whereas 14% received inappropriate shocks because of episodes of atrial arrhythmia. 17 Thus, in BS patients who have had atrial arrhythmia documented already, a dual-chamber ICD appears most appropriate. In BS patients without a history of atrial arrhythmia, meticulous programming of a single-chamber ICD is required. However, inappropriate shocks have occurred despite careful programming of the single-chamber ICD. 17 Thus, programmed atrial stimulation should be performed in BS patients in whom an ICD is indicated, and if sustained atrial arrhythmia is induced with single atrial premature stimulation, a dual-chamber ICD is recommended.
Study Limitations
The number of AF episodes might have been underestimated in the present study because of the eventual asymptomatic episodes. We did not compare the RA ERP of the BS patients and control patients; thus, we could not determine whether the RA ERP in the BS patients was shorter than in the control patients. Finally, we did not include paroxysmal AF patients without BS, so we could not compare the RA ERP and FPD of patients with BS and patients with paroxysmal AF without BS.
